Arava 20 mg Tablets (Leflunomide) for Rheumatoid Arthritis by Sanofi - 30 Film-Coated Tablets

160.60

Product description

"Arava" (manufactured by the global pharmaceutical leader Sanofi) is a highly trusted, clinical-grade prescription medication used to manage active rheumatic diseases. Powered by 20 mg of Leflunomide, a Disease-Modifying Antirheumatic Drug (DMARD), it works by suppressing the overactive immune system. This targeted action significantly reduces joint inflammation, swelling, and pain, while effectively slowing down the progression of structural joint damage to improve your physical function and daily mobility.



Key Medical Features & Clinical Benefits:

  • Active Rheumatoid Arthritis: Clinically proven to reduce joint tenderness, swelling, and severe morning stiffness associated with rheumatoid arthritis.
  • Psoriatic Arthritis Relief: Highly effective in managing and improving the symptoms of active psoriatic arthritis.
  • Prevents Joint Damage: Acts actively to slow down the underlying disease process, protecting the joints from irreversible structural damage.
  • Premium Global Standard: Formulated as easy-to-swallow, film-coated tablets by Sanofi, ensuring optimal absorption and pharmaceutical safety.

How to Use (Crucial Medical Instructions):

  • Swallow the tablets whole with a full glass of water. They can be taken with or without food.
  • Do NOT crush, chew, or break the tablets.
  • The dosage is strictly determined by your rheumatologist. The maintenance dose is typically one (1) tablet daily.


Warnings & Important Precautions:

  • Strict Pregnancy Warning: Absolutely contraindicated in pregnant women or those planning to conceive (applies to both men and women), as it can cause severe birth defects (teratogenic).
  • Liver & Blood Monitoring: Regular blood tests to monitor liver enzymes and blood cell counts are mandatory while taking this medication.
  • Store at room temperature (below 30°C), keep in the original packaging to protect from moisture, and store safely out of reach of children.